Global and United States Metabotropic Glutamate Receptor 1 Market Report & Forecast 2024-2031

Report ID: 1838769 | Published Date: Sep 2024 | No. of Page: 74 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Metabotropic Glutamate Receptor 1 Product Introduction
    1.2 Global Metabotropic Glutamate Receptor 1 Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Metabotropic Glutamate Receptor 1 Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Metabotropic Glutamate Receptor 1 Sales in Volume for the Year 2017-2028
    1.3 United States Metabotropic Glutamate Receptor 1 Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Metabotropic Glutamate Receptor 1 Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Metabotropic Glutamate Receptor 1 Sales in Volume for the Year 2017-2028
    1.4 Metabotropic Glutamate Receptor 1 Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Metabotropic Glutamate Receptor 1 in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Metabotropic Glutamate Receptor 1 Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Metabotropic Glutamate Receptor 1 Market Dynamics
        1.5.1 Metabotropic Glutamate Receptor 1 Industry Trends
        1.5.2 Metabotropic Glutamate Receptor 1 Market Drivers
        1.5.3 Metabotropic Glutamate Receptor 1 Market Challenges
        1.5.4 Metabotropic Glutamate Receptor 1 Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Metabotropic Glutamate Receptor 1 Market Segment by Type
        2.1.1 FC-311
        2.1.2 JBPOS-0101
        2.1.3 VU-0467558
        2.1.4 Others
    2.2 Global Metabotropic Glutamate Receptor 1 Market Size by Type
        2.2.1 Global Metabotropic Glutamate Receptor 1 Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Metabotropic Glutamate Receptor 1 Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Metabotropic Glutamate Receptor 1 Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Metabotropic Glutamate Receptor 1 Market Size by Type
        2.3.1 United States Metabotropic Glutamate Receptor 1 Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Metabotropic Glutamate Receptor 1 Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Metabotropic Glutamate Receptor 1 Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Metabotropic Glutamate Receptor 1 Market Segment by Application
        3.1.1 Depression
        3.1.2 DiGeorge Syndrome
        3.1.3 Infantile Spasm
        3.1.4 Others
    3.2 Global Metabotropic Glutamate Receptor 1 Market Size by Application
        3.2.1 Global Metabotropic Glutamate Receptor 1 Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Metabotropic Glutamate Receptor 1 Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Metabotropic Glutamate Receptor 1 Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Metabotropic Glutamate Receptor 1 Market Size by Application
        3.3.1 United States Metabotropic Glutamate Receptor 1 Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Metabotropic Glutamate Receptor 1 Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Metabotropic Glutamate Receptor 1 Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Metabotropic Glutamate Receptor 1 Competitor Landscape by Company
    4.1 Global Metabotropic Glutamate Receptor 1 Market Size by Company
        4.1.1 Top Global Metabotropic Glutamate Receptor 1 Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Metabotropic Glutamate Receptor 1 Revenue by Manufacturer (2017-2022)
        4.1.3 Global Metabotropic Glutamate Receptor 1 Sales by Manufacturer (2017-2022)
        4.1.4 Global Metabotropic Glutamate Receptor 1 Price by Manufacturer (2017-2022)
    4.2 Global Metabotropic Glutamate Receptor 1 Concentration Ratio (CR)
        4.2.1 Metabotropic Glutamate Receptor 1 Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Metabotropic Glutamate Receptor 1 in 2021
        4.2.3 Global Metabotropic Glutamate Receptor 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Metabotropic Glutamate Receptor 1 Manufacturing Base Distribution, Product Type
        4.3.1 Global Metabotropic Glutamate Receptor 1 Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Metabotropic Glutamate Receptor 1 Product Type
        4.3.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 1 Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Metabotropic Glutamate Receptor 1 Market Size by Company
        4.5.1 Top Metabotropic Glutamate Receptor 1 Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Metabotropic Glutamate Receptor 1 Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Metabotropic Glutamate Receptor 1 Sales by Players (2020, 2021 & 2022)
5 Global Metabotropic Glutamate Receptor 1 Market Size by Region
    5.1 Global Metabotropic Glutamate Receptor 1 Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Metabotropic Glutamate Receptor 1 Market Size in Volume by Region (2017-2028)
        5.2.1 Global Metabotropic Glutamate Receptor 1 Sales in Volume by Region: 2017-2022
        5.2.2 Global Metabotropic Glutamate Receptor 1 Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Metabotropic Glutamate Receptor 1 Market Size in Value by Region (2017-2028)
        5.3.1 Global Metabotropic Glutamate Receptor 1 Sales in Value by Region: 2017-2022
        5.3.2 Global Metabotropic Glutamate Receptor 1 Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Metabotropic Glutamate Receptor 1 Market Size YoY Growth 2017-2028
        6.1.2 North America Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Metabotropic Glutamate Receptor 1 Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Metabotropic Glutamate Receptor 1 Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Metabotropic Glutamate Receptor 1 Market Size YoY Growth 2017-2028
        6.3.2 Europe Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Metabotropic Glutamate Receptor 1 Market Size YoY Growth 2017-2028
        6.4.2 Latin America Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Metabotropic Glutamate Receptor 1 Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Metabotropic Glutamate Receptor 1 Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Aevi Genomic Medicine Inc
        7.1.1 Aevi Genomic Medicine Inc Corporation Information
        7.1.2 Aevi Genomic Medicine Inc Description and Business Overview
        7.1.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Products Offered
        7.1.5 Aevi Genomic Medicine Inc Recent Development
    7.2 Biohaven Pharmaceutical Holding Company Ltd
        7.2.1 Biohaven Pharmaceutical Holding Company Ltd Corporation Information
        7.2.2 Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
        7.2.3 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Products Offered
        7.2.5 Biohaven Pharmaceutical Holding Company Ltd Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Metabotropic Glutamate Receptor 1 Industry Chain Analysis
    8.2 Metabotropic Glutamate Receptor 1 Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Metabotropic Glutamate Receptor 1 Distributors
    8.3 Metabotropic Glutamate Receptor 1 Production Mode & Process
    8.4 Metabotropic Glutamate Receptor 1 Sales and Marketing
        8.4.1 Metabotropic Glutamate Receptor 1 Sales Channels
        8.4.2 Metabotropic Glutamate Receptor 1 Distributors
    8.5 Metabotropic Glutamate Receptor 1 Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Metabotropic Glutamate Receptor 1 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Metabotropic Glutamate Receptor 1 Market Trends
    Table 3. Metabotropic Glutamate Receptor 1 Market Drivers
    Table 4. Metabotropic Glutamate Receptor 1 Market Challenges
    Table 5. Metabotropic Glutamate Receptor 1 Market Restraints
    Table 6. Global Metabotropic Glutamate Receptor 1 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Metabotropic Glutamate Receptor 1 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Metabotropic Glutamate Receptor 1 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Metabotropic Glutamate Receptor 1 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Metabotropic Glutamate Receptor 1 Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Metabotropic Glutamate Receptor 1 Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Metabotropic Glutamate Receptor 1 Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Metabotropic Glutamate Receptor 1 Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Metabotropic Glutamate Receptor 1 Sales Share by Manufacturer, 2017-2022
    Table 15. Global Metabotropic Glutamate Receptor 1 Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Metabotropic Glutamate Receptor 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Metabotropic Glutamate Receptor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 1 as of 2021)
    Table 18. Top Players of Metabotropic Glutamate Receptor 1 in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Metabotropic Glutamate Receptor 1 Product Type
    Table 20. Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 1 Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Metabotropic Glutamate Receptor 1 Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Metabotropic Glutamate Receptor 1 Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Metabotropic Glutamate Receptor 1 Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Metabotropic Glutamate Receptor 1 Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Metabotropic Glutamate Receptor 1 Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Metabotropic Glutamate Receptor 1 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Metabotropic Glutamate Receptor 1 Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Metabotropic Glutamate Receptor 1 Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Metabotropic Glutamate Receptor 1 Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Metabotropic Glutamate Receptor 1 Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Metabotropic Glutamate Receptor 1 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Metabotropic Glutamate Receptor 1 Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Metabotropic Glutamate Receptor 1 Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Metabotropic Glutamate Receptor 1 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Metabotropic Glutamate Receptor 1 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Metabotropic Glutamate Receptor 1 Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Metabotropic Glutamate Receptor 1 Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Aevi Genomic Medicine Inc Corporation Information
    Table 43. Aevi Genomic Medicine Inc Description and Business Overview
    Table 44. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 1 Product
    Table 46. Aevi Genomic Medicine Inc Recent Development
    Table 47. Biohaven Pharmaceutical Holding Company Ltd Corporation Information
    Table 48. Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
    Table 49. Biohaven Pharmaceutical Holding Company Ltd Metabotropic Glutamate Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Biohaven Pharmaceutical Holding Company Ltd Product
    Table 51. Biohaven Pharmaceutical Holding Company Ltd Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Metabotropic Glutamate Receptor 1 Customers List
    Table 55. Metabotropic Glutamate Receptor 1 Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Metabotropic Glutamate Receptor 1 Product Picture
    Figure 2. Global Metabotropic Glutamate Receptor 1 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Metabotropic Glutamate Receptor 1 Market Size 2017-2028 (US$ Million)
    Figure 4. Global Metabotropic Glutamate Receptor 1 Sales 2017-2028 (K Pcs)
    Figure 5. United States Metabotropic Glutamate Receptor 1 Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Metabotropic Glutamate Receptor 1 Market Size 2017-2028 (US$ Million)
    Figure 7. United States Metabotropic Glutamate Receptor 1 Sales 2017-2028 (K Pcs)
    Figure 8. United States Metabotropic Glutamate Receptor 1 Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Metabotropic Glutamate Receptor 1 Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Metabotropic Glutamate Receptor 1 Report Years Considered
    Figure 11. Product Picture of FC-311
    Figure 12. Product Picture of JBPOS-0101
    Figure 13. Product Picture of VU-0467558
    Figure 14. Product Picture of Others
    Figure 15. Global Metabotropic Glutamate Receptor 1 Market Share by Type in 2022 & 2028
    Figure 16. Global Metabotropic Glutamate Receptor 1 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Metabotropic Glutamate Receptor 1 Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Metabotropic Glutamate Receptor 1 Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Metabotropic Glutamate Receptor 1 Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Metabotropic Glutamate Receptor 1 Market Share by Type in 2022 & 2028
    Figure 22. United States Metabotropic Glutamate Receptor 1 Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Metabotropic Glutamate Receptor 1 Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Metabotropic Glutamate Receptor 1 Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Metabotropic Glutamate Receptor 1 Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Metabotropic Glutamate Receptor 1 Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Depression
    Figure 28. Product Picture of DiGeorge Syndrome
    Figure 29. Product Picture of Infantile Spasm
    Figure 30. Product Picture of Others
    Figure 31. Global Metabotropic Glutamate Receptor 1 Market Share by Application in 2022 & 2028
    Figure 32. Global Metabotropic Glutamate Receptor 1 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Metabotropic Glutamate Receptor 1 Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Metabotropic Glutamate Receptor 1 Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Metabotropic Glutamate Receptor 1 Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Metabotropic Glutamate Receptor 1 Market Share by Application in 2022 & 2028
    Figure 38. United States Metabotropic Glutamate Receptor 1 Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Metabotropic Glutamate Receptor 1 Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Metabotropic Glutamate Receptor 1 Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Metabotropic Glutamate Receptor 1 Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Metabotropic Glutamate Receptor 1 Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Metabotropic Glutamate Receptor 1 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Metabotropic Glutamate Receptor 1 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Metabotropic Glutamate Receptor 1 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Metabotropic Glutamate Receptor 1 Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Metabotropic Glutamate Receptor 1 Value Chain
    Figure 77. Metabotropic Glutamate Receptor 1 Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aevi Genomic Medicine Inc
Biohaven Pharmaceutical Holding Company Ltd
Frequently Asked Questions
Metabotropic Glutamate Receptor 1 report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metabotropic Glutamate Receptor 1 report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metabotropic Glutamate Receptor 1 report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports